Zhixian Wu

xia men university

H指数:24

被引数:2,409

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: A study based on transcriptomic signature and bioinformatics analysis

OCIAD2作为胰腺癌的新型预后和疗效生物标志物：一项基于转录组特征和生物信息学分析的研究

PLOS COMPUTATIONAL BIOLOGY

IF3.6

2025-10-010

PRE

ADAMTSL2 is an independent predictor for the prognosis of gastric cancer

ADAMTSL2是胃癌预后的独立预测因子。

DISCOVER ONCOLOGY

IF2.9

2025-04-190

Novel high-entropy oxides with ultra-long cycle life as cathode materials for aqueous zinc-ion batteries

具有超长循环寿命的新型高熵氧化物作为水性锌离子电池的正极材料

JOURNAL OF POWER SOURCES

IF7.9

2025-04-010

PRE

Dual Photoredox- and Titanium Catalysis-Enabled Three-Component Radical Propargylation of Aldehydes with 1,3-Enynes

ORGANIC LETTERS

IF5

2025-03-010

PRE

Peptide-Engineered Interface to Improve the Efficiency of Pure Red Tin Halide Perovskite LEDs by Controlling Crystallization and Reducing Oxidation

ACS APPLIED ELECTRONIC MATERIALS

IF4.7

2025-02-140

PRE

Development of bone-mimicking resin for 3D printing with enhanced mechanical properties using ceramic filler

POLYMER TESTING

IF6

2025-02-010

OAAI

Manipulating the d-band center of bimetallic molybdenum vanadate for high performance aqueous zinc-ion battery

操纵双金属钒酸钼的d带中心用于高性能水性锌离子电池

JOURNAL OF COLLOID AND INTERFACE SCIENCE

IF9.7

2025-02-010

PRE

Indium Mediated Reformatsky-Type Allylation of N-tert-Butanesulfinyl Iminoester with 1,3-Butadiene

ORGANIC LETTERS

IF5

2024-12-200

PRE

Unilateral and bilateral radioactive stent insertion in patients diagnosed with inoperable hilar cholangiocarcinoma: a comparative analysis

FRONTIERS IN ONCOLOGY

IF3.3

2024-10-010

OAAI

Bone marrow mesenchymal stem cell and mononuclear cell combination therapy in patients with type 2 diabetes mellitus: a randomized controlled study with 8-year follow-up

STEM CELL RESEARCH & THERAPY

IF7.3

2024-09-300

OAAI

Calcium polypeptide mitigates Cd toxicity in rice via reducing oxidative stress and regulating pectin modification

钙多肽通过降低氧化应激和调节果胶改性减轻水稻镉毒性

PLANT CELL REPORTS

IF4.5

2024-06-063

PRE

Titanium catalyzed [2σ+2π] cycloaddition of bicyclo[1.1.0]-butanes with 1,3-dienes for efficient synthesis of stilbene bioisosteres

NATURE COMMUNICATIONS

IF15.7

2024-05-2314

OAAI

Low-Dimensional Phase Distribution of Quasi-2D Perovskites Induced by Interfacial Effect Enables Efficient Blue Lighting-Emitting Diodes

ADVANCED OPTICAL MATERIALS

IF7.2

2023-10-124

Trajectories of α-fetoprotein and unresectable hepatocellular carcinoma outcomes receiving atezolizumab plus bevacizumab: a secondary analysis of IMbrave150 study

BRITISH JOURNAL OF CANCER

IF6.8

2023-07-085

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-135

OAAI

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression

肝细胞癌中CLGN的上调可能受hsa-miR-194-3p调节并与患者进展相关

FRONTIERS IN ONCOLOGY

IF3.3

2023-01-092

OAAI

Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients (vol 22, 1354, 2022)

BMC CANCER

IF3.4

2023-01-051

OAAI

Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients

BMC CANCER

IF3.4

2022-12-265

OAAI

Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis

Fas/FasL和补体激活与慢性活动性epstein-barr病毒肝炎有关

clinical and translational gastroenterology

IF4.2

2022-09-141

OAAI

Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study

ECLINICALMEDICINE

IF10

2022-05-0118

OAAI

Zhixian Wu

个人简介

教育背景

工作经历

荣誉奖项

研究方向